Chromadex Co Founder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ChromaDex, a Global Authority on Nicotinamide Adenine Dinucleotide (NAD+), Celebrates the 10th Anniversary of its ChromaDex External Research Program (CERP™), the Industry Leading Research Program Advancing the Science of NAD+ and Healthy Aging

Through CERP™, over 275 global research agreements with 235+ independent, expert investigators are uncovering the full potential of NAD+ by researching ChromaDex’s Niagen® ingredient,. | June 16, 2023

University of washingtonUnited statesEteläuomen läiCharalampos tzoulisKevin obrienKirsi pietilFrank jakschUniversity of osloUniversity of ouluChromadex corpUniversity of helsinkiUniversity of bergenHaukeland university hospitalEija pirinen university of helsinkiMetabolism centerCharles brenner alfrede mann family foundation

ChromaDex Shares Preclinical Research Findings and Scientific Initiations from the ChromaDex External Research Program (CERP)

ChromaDex Shares Preclinical Research Findings and Scientific Initiations from the ChromaDex External Research Program (CERP)
financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.

United statesFrank jakschAlex worshamCharles brennerResearch drug discovery conferenceChromadex external research programAlfrede mann family foundationChromadex corpProceedings of the national academy sciencesChromadex coGlobal marketing communicationsEuropean unionNational academyCardiovascular medicineinvestigatedChromadex co founderExecutive chairman